AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24397061 — intervention group
Group type: COMPARATOR
Intervention: Tab diclofenac 50 mg twice a day and topical NSAID cream application twice a day for 3 weeks
Number of subjects: 60
Study 19935437 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Medical Learning (IML) educational intervention
Number of subjects: 0
Study 19935437 — intervention group
Group type: EXPERIMENTAL
Intervention: Premeeting knowledge assessment
Number of subjects: 0
Study 19935437 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert opinion presentations
Number of subjects: 0
Study 19935437 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmeeting surveys
Number of subjects: 0
Study 18706164 — intervention group
Group type: EXPERIMENTAL
Intervention: OROS‐MPH (18 mg/time, once daily)
Number of subjects: 99
Study 18706164 — intervention group
Group type: COMPARATOR
Intervention: IR‐MPH (5 mg/time, twice or three times per day)
Number of subjects: 99
Study 15482357 — intervention group
Group type: EXPERIMENTAL
Intervention: Effervescent ASA (1000 mg)
Number of subjects: 312
Study 15482357 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (400 mg)
Number of subjects: 312
Study 15482357 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan (50 mg)
Number of subjects: 312
Study 15482357 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 312
Study 11182878 — intervention group
Group type: EXPERIMENTAL
Intervention: PAS intervention (structured counselling programme, information leaflet, follow-up weekly for the first 4 weeks then monthly as needed)
Number of subjects: 484
Study 11182878 — intervention group
Group type: COMPARATOR
Intervention: Control group (ad hoc advice from pharmacists)
Number of subjects: 484
Study 9608351 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 25 mg per day
Number of subjects: 46
Study 9608351 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 50 mg per day
Number of subjects: 46
Study 9608351 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 75 mg per day
Number of subjects: 46
Study 9608351 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 7995316 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine-TTS (1.5 mg)
Number of subjects: 6
Study 7995316 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 3070050 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity scheduling
Number of subjects: 40
Study 3070050 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation training
Number of subjects: 40
Study 3070050 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 40
Study 30014723 — intervention group
Group type: EXPERIMENTAL
Intervention: SSMS (products that appeared as a single serving and contain multiple servings)
Number of subjects: 60
Study 30014723 — intervention group
Group type: COMPARATOR
Intervention: SSSS (products that appeared as a single serving and contain a single serving)
Number of subjects: 60
Study 30014723 — intervention group
Group type: COMPARATOR
Intervention: MSMS (products that both appear as a multi‐serving and contain multiple servings)
Number of subjects: 60
Study 28751562 — intervention group
Group type: EXPERIMENTAL
Intervention: ixazomib-lenalidomide-dexamethasone (ixazomib-Rd)
Number of subjects: 722
Study 28751562 — intervention group
Group type: COMPARATOR
Intervention: placebo-lenalidomide-dexamethasone (placebo-Rd)
Number of subjects: 722
Study 26269539 — intervention group
Group type: EXPERIMENTAL
Intervention: IVF-SET
Number of subjects: 602
Study 26269539 — intervention group
Group type: EXPERIMENTAL
Intervention: IVF-MNC
Number of subjects: 602
Study 26269539 — intervention group
Group type: COMPARATOR
Intervention: IUI-COH
Number of subjects: 602
Study 26269539 — intervention group
Group type: COMPARATOR
Intervention: IVF-SET vs IUI-COH
Number of subjects: 602
Study 26269539 — intervention group
Group type: COMPARATOR
Intervention: IVF-MNC vs IUI-COH
Number of subjects: 602
Study 24045625 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic phase (DP) of lymphoscintigraphy
Number of subjects: 161
Study 24045625 — intervention group
Group type: COMPARATOR
Intervention: Early and delayed planar images (EPI and DPI)
Number of subjects: 161
Study 21113636 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal epidural injection with 20 ml volume (5 ml contrast, 2 ml Triamcinolone, 13 ml local anaesthetic)
Number of subjects: 52
Study 21113636 — intervention group
Group type: EXPERIMENTAL
Intervention: 0° Trendelenburg tilt
Number of subjects: 52
Study 21113636 — intervention group
Group type: EXPERIMENTAL
Intervention: 30° Trendelenburg tilt
Number of subjects: 52
Study 21113636 — intervention group
Group type: EXPERIMENTAL
Intervention: Eradication of lumbar lordosis
Number of subjects: 52
Study 18290733 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine (5 injections of 2 mL 0.5% ropivacaine around the ureteral orifice)
Number of subjects: 22
Study 18290733 — intervention group
Group type: COMPARATOR
Intervention: Control (5 injections of 2 mL of 0.9% normal saline)
Number of subjects: 22
Study 16443721 — intervention group
Group type: EXPERIMENTAL
Intervention: MMPI‐A and MMPI‐2 with 10%, 20%, 30%, 40%, and 50% randomly inserted true or false responses
Number of subjects: 100
Study 16443721 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (normative sample without modifications)
Number of subjects: 100
Study 12589284 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection molded and microwave polymerized (Microbase)
Number of subjects: 40
Study 12589284 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection molded and microwave polymerized (Acron MC)
Number of subjects: 40
Study 12589284 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection molded and conventionally polymerized (Success)
Number of subjects: 40
Study 12589284 — intervention group
Group type: COMPARATOR
Intervention: Compression molded and conventionally polymerized (control group)
Number of subjects: 40
Study 10831645 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol (2.4+/‐1.0 microg/day, p.o.)
Number of subjects: 20
Study 10831645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9349662 — intervention group
Group type: COMPARATOR
Intervention: MK-677 (25 mg)
Number of subjects: 14
Study 8449202 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulphate (70 mmol)
Number of subjects: 140
Study 8449202 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 8449202 — intervention group
Group type: EXPERIMENTAL
Intervention: High serum magnesium levels (highest quartile)
Number of subjects: 140
Study 8449202 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-AF patients
Number of subjects: 140
Study 8449202 — intervention group
Group type: EXPERIMENTAL
Intervention: High magnesium levels
Number of subjects: 140
Study 3534854 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 47
Study 3534854 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 47
Study 3534854 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril + Hydrochlorothiazide
Number of subjects: 47
Study 31344185 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-quality mother-child interaction
Number of subjects: 181
Study 31344185 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding (EBF) <6 months
Number of subjects: 181
Study 31344185 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner does not help with childcare
Number of subjects: 181
Study 31344185 — intervention group
Group type: COMPARATOR
Intervention: Postpartum depressive symptoms
Number of subjects: 181
Study 30194533 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component workplace intervention program with environmental changes
Number of subjects: 208
Study 30194533 — intervention group
Group type: COMPARATOR
Intervention: Control group with feedback and basic occupational health services
Number of subjects: 208
Study 26650571 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicaid coverage
Number of subjects: 16204
Study 26650571 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Medicaid coverage)
Number of subjects: 16204
Study 24275677 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab 60mg every 6 months
Number of subjects: 247
Study 24275677 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 70mg weekly
Number of subjects: 247
Study 24275677 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 247
Study 22143734 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% NaF solution
Number of subjects: 25
Study 22143734 — intervention group
Group type: EXPERIMENTAL
Intervention: GLUMA® (HEMA-G)
Number of subjects: 25
Study 22143734 — intervention group
Group type: EXPERIMENTAL
Intervention: NaF-iontophoresis
Number of subjects: 25
Study 22143734 — intervention group
Group type: COMPARATOR
Intervention: Placebo (distilled water)
Number of subjects: 25
Study 20643661 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for congenital heart defects (CHD)
Number of subjects: 1158
Study 20643661 — intervention group
Group type: COMPARATOR
Intervention: Overall prevalence of known CHD
Number of subjects: 1158
Study 20643661 — intervention group
Group type: COMPARATOR
Intervention: Overall prevalence of CHD in adult Down's syndrome patients
Number of subjects: 1158
Study 18806016 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 70 (70 bpm)
Number of subjects: 40
Study 18806016 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 90 (90 bpm)
Number of subjects: 40
Study 15070605 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosulfan blue dye intradermally at the biopsy site (n=60)
Number of subjects: 84
Study 15070605 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dye, n=24)
Number of subjects: 84
Study 11199756 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic apex locator
Number of subjects: 58
Study 11199756 — intervention group
Group type: COMPARATOR
Intervention: Radiographic estimate
Number of subjects: 58
Study 10170091 — intervention group
Group type: EXPERIMENTAL
Intervention: Permethrin impregnated bednets
Number of subjects: 16800
Study 7871004 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron (4 mg orally)
Number of subjects: 16
Study 7871004 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study 3096345 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin/Erythromycin prophylaxis
Number of subjects: 100
Study 3096345 — intervention group
Group type: COMPARATOR
Intervention: Control (no antibiotic prophylaxis)
Number of subjects: 100
Study 3096345 — intervention group
Group type: COMPARATOR
Intervention: Control (no antibiotic prophylaxis) for wounds >1 cm requiring suturing
Number of subjects: 100
Study 30843703 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intention intervention and antismoking messages
Number of subjects: 6155
Study 29233164 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper thoracic spine mobilization and mobility exercise
Number of subjects: 32
Study 29233164 — intervention group
Group type: COMPARATOR
Intervention: Upper cervical spine mobilization and stabilization exercise
Number of subjects: 32
Study 24890912 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronabinol therapy
Number of subjects: 24
Study 24890912 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 24162387 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil continuous infusion (5-FUci)
Number of subjects: 319
Study 24162387 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-line chemotherapy with new drugs
Number of subjects: 319
Study 22947287 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.5-mm capsulotomy group (9 eyes)
Number of subjects: 11
Study 22947287 — intervention group
Group type: COMPARATOR
Intervention: 6.0-mm capsulotomy group (8 eyes)
Number of subjects: 11
Study 19409749 — intervention group
Group type: EXPERIMENTAL
Intervention: Didactic learning
Number of subjects: 156
Study 19409749 — intervention group
Group type: COMPARATOR
Intervention: Active learning
Number of subjects: 156
Study 17332131 — intervention group
Group type: COMPARATOR
Intervention: Open reduction and screw fixation
Number of subjects: 41
Study 17332131 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary arthrodesis of the medial two or three rays
Number of subjects: 41
Study 15136776 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived stress scale
Number of subjects: 277
Study 15136776 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression screener
Number of subjects: 277
Study 15136776 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy for quitting smoking
Number of subjects: 277
Study 15136776 — intervention group
Group type: EXPERIMENTAL
Intervention: Sense of mastery scale
Number of subjects: 277
Study 15136776 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-related quality of life measures from the Medical Outcomes Study
Number of subjects: 277
Study 11089516 — intervention group
Group type: EXPERIMENTAL
Intervention: Rizatriptan 10 mg
Number of subjects: 0
Study 11089516 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 10436948 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefetamet pivoxil (CAT) 250‐500 mg, twice daily orally for 7‐10 days
Number of subjects: 99
Study 10436948 — intervention group
Group type: COMPARATOR
Intervention: Cefixime (CFX) 200 mg, twice daily orally for 7‐10 days
Number of subjects: 99
Study 8248693 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracervical instillation of prostaglandins E2 (Prepidil)
Number of subjects: 184
Study 8248693 — intervention group
Group type: COMPARATOR
Intervention: Intracervical Foley catheter with balloon inflated to 50 cc
Number of subjects: 184
Study 8248693 — intervention group
Group type: COMPARATOR
Intervention: Extraamniotic injection of prostaglandins E2 via a Foley catheter with balloon inflated to 50 cc
Number of subjects: 184
Study 3516907 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% benzydamine cream
Number of subjects: 43
Study 3516907 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 31282567 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous pantoprazole 40 mg once daily during ICU stay
Number of subjects: 3261
Study 31282567 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline) once daily during ICU stay
Number of subjects: 3261
Study 28657798 — intervention group
Group type: EXPERIMENTAL
Intervention: Online dating scenario
Number of subjects: 0
Study 28657798 — intervention group
Group type: COMPARATOR
Intervention: Offline dating scenario
Number of subjects: 0
Study 26823213 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory women's groups facilitated by ASHAs
Number of subjects: 156519
Study 26823213 — intervention group
Group type: COMPARATOR
Intervention: Control (no women's groups)
Number of subjects: 156519
Study 25627344 — intervention group
Group type: EXPERIMENTAL
Intervention: Banking Time intervention
Number of subjects: 59
Study 23930551 — intervention group
Group type: EXPERIMENTAL
Intervention: GAKIC (10.2 g)
Number of subjects: 7
Study 23930551 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 23930551 — intervention group
Group type: COMPARATOR
Intervention: GAKIC and Placebo
Number of subjects: 7
Study 20227056 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 0
Study 20227056 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 0
Study 18823311 — intervention group
Group type: EXPERIMENTAL
Intervention: Triage Risk Stratification Tool (TRST) score of 2 or greater
Number of subjects: 788
Study 16489434 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg baclofen (BAC)
Number of subjects: 9
Study 16489434 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 9
Study 14689713 — intervention group
Group type: EXPERIMENTAL
Intervention: isosorbide dinitrate (ID)
Number of subjects: 109
Study 14689713 — intervention group
Group type: EXPERIMENTAL
Intervention: sustac-forte (SF)
Number of subjects: 109
Study 14689713 — intervention group
Group type: EXPERIMENTAL
Intervention: isosorbide dinitrate retard (IDR)
Number of subjects: 109
Study 14689713 — intervention group
Group type: EXPERIMENTAL
Intervention: trinitrolong (TN)
Number of subjects: 109
Study 14689713 — intervention group
Group type: EXPERIMENTAL
Intervention: ID, SF, IDR
Number of subjects: 109
Study 14689713 — intervention group
Group type: EXPERIMENTAL
Intervention: TN therapy
Number of subjects: 109
Study 14689713 — intervention group
Group type: EXPERIMENTAL
Intervention: ID, SF
Number of subjects: 109
Study 10953903 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking intervention for 18 weeks
Number of subjects: 97
Study 10953903 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 16)
Number of subjects: 97
Study 8824690 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichloroacetate (DCA) 46 mg kg-1 infused in 30 min
Number of subjects: 11
Study 8824690 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichloroacetate (DCA) 46 mg kg-1 infused in 30 min (2 doses)
Number of subjects: 11
Study 8824690 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 11
Study 1314144 — intervention group
Group type: COMPARATOR
Intervention: ICI 169,369 (30 mg x 2)
Number of subjects: 21
Study 1314144 — intervention group
Group type: COMPARATOR
Intervention: ICI 169,369 (80 mg x 2)
Number of subjects: 21
Study 1314144 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 21
Study 30777118 — intervention group
Group type: EXPERIMENTAL
Intervention: 100,000 IU vitamin D3 (two oral doses, once in the fall and once in the winter)
Number of subjects: 47
Study 30777118 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 47
Study 27389681 — intervention group
Group type: EXPERIMENTAL
Intervention: PA21 (sucroferric oxyhydroxide) 250 mg, 500 mg, 750 mg, or 1000 mg three times/day for 6 weeks
Number of subjects: 183
Study 27389681 — intervention group
Group type: EXPERIMENTAL
Intervention: PA21 (sucroferric oxyhydroxide)
Number of subjects: 183
Study 27389681 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 183
Study 25559899 — intervention group
Group type: EXPERIMENTAL
Intervention: Deadlift training under supervision of a physical therapist
Number of subjects: 35
Study 25559899 — intervention group
Group type: EXPERIMENTAL
Intervention: Deadlift training
Number of subjects: 35
Study 24742292 — intervention group
Group type: EXPERIMENTAL
Intervention: 5HT antagonist
Number of subjects: 10
Study 24742292 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitor (SSRI)
Number of subjects: 10
Study 21564307 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery and standard rehabilitation
Number of subjects: 21
Study 21564307 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation alone (control)
Number of subjects: 21
Study 19707983 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 20 mg/d for 6 days
Number of subjects: 47
Study 19707983 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 days
Number of subjects: 47
Study 18027401 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoral fluoride-releasing system (IFRS)
Number of subjects: 22
Study 18027401 — intervention group
Group type: COMPARATOR
Intervention: 0.4% stannous fluoride gel (control group)
Number of subjects: 22
Study 18027401 — intervention group
Group type: EXPERIMENTAL
Intervention: IFRS
Number of subjects: 22
Study 16107445 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity gender-concordant group intervention sessions
Number of subjects: 180
Study 16107445 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity gender-concordant group intervention sessions
Number of subjects: 180
Study 12392386 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol (12 or 24 microg)
Number of subjects: 18
Study 12392386 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol (180 microg)
Number of subjects: 18
Study 12392386 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 10540090 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 2 microg x kg‐1
Number of subjects: 60
Study 10540090 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 50 microg x kg‐1
Number of subjects: 60
Study 10540090 — intervention group
Group type: EXPERIMENTAL
Intervention: Suxamethonium 1 mg x kg‐1
Number of subjects: 60
Study 8653553 — intervention group
Group type: EXPERIMENTAL
Intervention: Low ambient temperature (4 degrees C)
Number of subjects: 0
Study 8653553 — intervention group
Group type: COMPARATOR
Intervention: Room temperature
Number of subjects: 0
Study 2279258 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibopamine 100 mg t.i.d.
Number of subjects: 52
Study 2279258 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 394144 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol (400 mg per day for three days)
Number of subjects: 12
Study 394144 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 31200893 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular trivalent inactivated influenza vaccine (IIV3)
Number of subjects: 3208
Study 31200893 — intervention group
Group type: COMPARATOR
Intervention: Inactivated poliovirus vaccine (IPV)
Number of subjects: 3208
Study 29242550 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation
Number of subjects: 256
Study 29242550 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 256
Study 24784420 — intervention group
Group type: EXPERIMENTAL
Intervention: Genomic classifier (GC) test results
Number of subjects: 145
Study 24784420 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant radiation therapy (ART) recommendations without GC test result knowledge
Number of subjects: 145
Study 24784420 — intervention group
Group type: COMPARATOR
Intervention: Observation recommendations without GC test result knowledge
Number of subjects: 145
Study 24784420 — intervention group
Group type: EXPERIMENTAL
Intervention: Low risk disease according to the GC test
Number of subjects: 145
Study 24784420 — intervention group
Group type: EXPERIMENTAL
Intervention: High risk disease according to the GC test
Number of subjects: 145
Study 24784420 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment intensity
Number of subjects: 145